Michael Harsh - 03 Jan 2022 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Michael Harsh by Mark Busch, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 16:05:15 UTC
Next filing
30 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NDRA Stock Options Award $0 +12,000 $0.000000 12,000 03 Jan 2022 Common Stock 12,000 $0.7400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy.